Joao Gorgulho

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Patients Undergoing

Replacement Therapy

Peripheral Blood

Top Venues

British journal of cancer

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Joao Gorgulho, Christoph Roderburg, Fabian Beier, Carsten Bokemeyer, Tim Henrik Brümmendorf, Sven H Loosen, Tom Luedde
Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies. British journal of cancer (2024)
Joao Gorgulho, Christoph Roderburg, Fabian Beier, Carsten Bokemeyer, Tim Henrik Brümmendorf, Sven H Loosen, Tom Luedde
Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies. British journal of cancer 130 (6) (2024)
Joao Gorgulho, Christoph Roderburg, Fabian Beier, Carsten Bokemeyer, Tim Henrik Brümmendorf, Sven H Loosen, Tom Luedde
Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies. British journal of cancer 130 (6) (2024)
Joao Gorgulho, Christoph Roderburg, Fabian Beier, Carsten Bokemeyer, Tim Henrik Brümmendorf, Sven H Loosen, Tom Luedde
Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies. British journal of cancer 130 (6) (2024)
Joao Gorgulho, Christoph Roderburg, Felix Heymann, Maximilian Schulze-Hagen, Fabian Beier, Mihael Vucur, Jakob N Kather, Narmin Ghaffari Laleh, Frank Tacke, Tim H Brümmendorf, Tom Luedde, Sven H Loosen
Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies. International journal of cancer 149 (5) (2021)